Prognostic factors in Vogt-Koyanagi-Harada disease

International Ophthalmology

Volumn 27, Issue 2-3, 2007, Pages 201-210

  Al Kharashi, Abdullah S ^a   Aldibhi, Hassan ^b   Al Fraykh, Hamad ^b   Kangave, Dustan ^a   Abu El Asrar, Ahmed M ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Complications; Corticosteroid therapy; Recurrent uveitis; Vogt Koyanagi Harada disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPLEGIC AGENT; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGE; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL FEATURE; CONFIDENCE INTERVAL; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HEADACHE; HEARING IMPAIRMENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; OUTCOMES RESEARCH; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; RISK REDUCTION; SAUDI ARABIA; SCHOOL CHILD; SLIT LAMP; SUBRETINAL NEOVASCULARIZATION; TINNITUS; UNIVARIATE ANALYSIS; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY;

EID: 34250310877     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9062-9     Document Type: Article

References (22)

1. Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39:265-292
2. Kobayashi H, Kokubo T, Takahashi M, Sato K, Miyokawa N, Kimura S, Kinouchi R, Katagiri M (1998) Tyrosine epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Immunogenetics 47:398-403
3. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S (2000) Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165:7323-7329
4. Yamaki K, Kondo I, Nakamura H, Miyando M, Konno S, Sakuragi S (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis Rats. Exp Eye Res 71:361-369
5. Gocho K, Kondo I, Yamaki K (2001) Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 42:2004-2009
6. Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S (2001) Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada disease. Curr Eye Res 22:312-318
7. Abu El-Asrar AM, Struyf S, Descamps FJ, Al-Obeidan SA, Proost P, VanDamme J, Opdenakker G, Geboes K (2004) Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol 138:401-411
8. Read RW, Rechodouni A, Butani N, Johnston R, Labree LD, Smith RE, Rao NA (2001) Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:599-606
9. Ohno S, Minakawa R, Matsuda H (1988) Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 32:334-343
10. Ohno S, Char DH, Kimura SJ, O'Connor GR (1977) Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 83:735-740
11. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 131:647-652
12. Forrester JV, Ben Ezra D, Nussenblatt RB, Tabbara KF, Timonen P (1994) Grading of intermediate and posterior uveitis. In: Tabbara KF, Nussenblatt RB (eds) Posterior uveitis: Diagnosis and management. Butterworth-Heinemann, Boston, pp 5-18
13. Rubsamen PE, Gass DM (1991) Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109:682-687
14. Moorthy RS, Rajeev B, Smith RE, Rao NA (1994) Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 118:197-204
15. Forster DI, Rao NA, Hill RA, Nguyen QH, Baerveldt G (1993) Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. Ophthalmology 100:613-618
16. Moorthy RS, Chong LP, Smith RE, Rao NA (1993) Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 116:164-170
17. Kuo IC, Rechdouni A, Rao NA, Johnston RH, Morgolis TP, Cunningham ET Jr (2000) Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 107:1721-1728
18. Sonoda S, Nakao K, Ohba N (1999) Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 43:113-119
19. Hayasaka S, Okabe H, Takahashi J (1982) Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefe's Arch Clin Exp Ophthalmol 218:9-13
20. Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefe's Arch Clin Exp Ophthalmol 240:878-882
21. Rathinam SR, Vijayalakshmi P, Namperumalsamy P, Nozik RA, Cunningham ET Jr (1998) Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inflamm 6:155-161
22. Tabbara KF, Chavis PS, Freeman WR (1998) Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 76:723-726